Johnson & Johnson Loses Key Tuberculosis Drug Patent In India
India accounted for nearly 29% of 10.6 million tuberculosis cases worldwide (File)New Delhi: The Indian Patent Office on Thursday rejected US pharmaceutical giant Johnson and Johnson’s application to extend its…